48,830
edits
Difference between revisions of "Classification of urothelial carcinoma by immunohistochemistry"
Jump to navigation
Jump to search
Classification of urothelial carcinoma by immunohistochemistry (view source)
Revision as of 17:30, 26 October 2021
, 17:30, 26 October 2021→A simple classification of urothelial carcinoma by immunohistochemistry
| Line 12: | Line 12: | ||
{{familytree | C01 | | | | C02 | | | | | | | | | | | |C01='''Genomically unstable'''<br>'''p16 +ve'''|C02='''Urothelial-like'''<br>'''p16 -ve'''}} | {{familytree | C01 | | | | C02 | | | | | | | | | | | |C01='''Genomically unstable'''<br>'''p16 +ve'''|C02='''Urothelial-like'''<br>'''p16 -ve'''}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Note: | |||
*Twenty percent of the tumour cells is considered the cut-off for ''positive'' and ''negative''.<ref name=pmid34103388/> | |||
==Sign out== | ==Sign out== | ||